Study Finds MedCline™ Significantly Improves Symptoms in Patients with Laryngopharyngeal or “Silent” Reflux

A new study in the American Journal of Otolaryngology finds that a medical device is helpful in significantly improving symptoms in patients with laryngopharyngeal reflux (LPR).  Researchers at The Cleveland Clinic studied the non-invasive medical device, called MedCline™, and found that it significantly improved self-reported symptoms of nocturnal reflux, as well as symptoms specific to LPR, such as chronic cough, throat clearing, hoarseness of voice, and chronic sinusitis or rhinitis. The device is available without a prescription.

This most recent study is in addition to five clinical trials which found MedCline™ to be an effective treatment in gastroesophageal reflux disease (GERD) patients suffering with nocturnal reflux symptoms. Highlights from these studies include:

•    87% less esophageal acid exposure at night
•    72% reduction in nocturnal GERD symptom scores
•    95% reported an overall improvement in sleep quality
•    75% reported less difficulty with sliding down at night

Abstracts for each of these studies can be viewed at and downloaded from: https://medcline.com/proven-results/.

This most recently publication further demonstrates the ability of the MedCline™ device to treat multiple forms of reflux. Since its inception, clinical studies have been performed with patients suffering with typical GERD, LPR or “silent reflux,” gestational (or pregnancy) reflux, as well post-esophagectomy patients, and post lung transplant patients who are at higher risk of lung rejection due to reflux.

Additional MedCline™ studies are scheduled to be presented at national medical conferences later this year.